Physician profile
Bradley A Tan
NPI 1972509495
$1,370.47
in general payments reported to CMS, 2019-2025
13 companies · $43.65 in 2025
The $43.65 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $599 · 2020: $42.53 · 2021: $65.92 · 2022: $418 · 2023: $60.21 · 2024: $141 · 2025: $43.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $244.33 | 2019-2023 | Saxenda, Wegovy |
| Biohaven Pharmaceutical Holding Company LTD. | $206.59 | 2022 | |
| Novartis Pharmaceuticals Corporation | $194.36 | 2019 | |
| Abbvie INC. | $184.29 | 2021-2025 | Vraylar |
| Pfizer INC. | $110.48 | 2020-2025 | |
| Allergan, INC. | $108.32 | 2019 | |
| Eisai INC. | $96.94 | 2024 | |
| Merck Sharp & Dohme LLC | $65.94 | 2022 | |
| Lilly USA, LLC | $41.72 | 2019 | |
| Dexcom, INC. | $38.58 | 2022-2024 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $31.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.47 | 2019-2022 | |
| Boston Scientific Corporation | $19.35 | 2024 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.